Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk score-guided early ibuprofen closure of patent ductus arteriosus in extremely preterm infants
ISRCTN13281214Phase 3Completed
- Sponsor
- RCSI University of Medicine and Health Sciences
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in patent ductus arteriosus (PDA) comparing Ibuprofen with Placebo (2 arms). Primary endpoint: Chronic lung disease and/or death before discharge. Started Sep 2016; status: completed.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on ISRCTN13281214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13281214.